Jpmorgan Chase & Co »

Quince Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Quince Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $2 2 1.00